BIO Horizon Hangout hosted by J.P. Morgan + DLA Piper

​Join us at the BIO Horizon Hangout, an exclusive rooftop networking event designed to foster meaningful connections in the life sciences industry. Whether you're aiming to expand your network, explore potential partnerships or simply enjoy the company of like-minded individuals, this event is the perfect setting.

​Taking place immediately after the main stage programming conclusion at nearby BIO International Convention, the BIO Horizon Hangout offers a unique opportunity to engage with industry leaders and innovators who are shaping the future of life sciences. The event will feature brief remarks from sector leader experts at J.P. Morgan and DLA Piper, providing invaluable perspectives on industry trends and advancements. Don't miss this chance to be part of an afternoon dedicated to advancing the future of life sciences!

​*Please note that this event is invite-only and invitations are non-transferable, ensuring a curated experience for all attendees.

​About the Hosts : 

​J.P. Morgan 

​J.P. Morgan serves venture-backed and high-growth startups, founders, and venture capital firms across the globe, with a strong focus on the life sciences industry. The firm provides deep industry expertise in areas such as biotechnology, pharmaceuticals, and medical devices, offering local support and global products and services tailored to the unique needs of life sciences companies. With a robust network of investors and partners, J.P. Morgan is well-equipped to meet the commercial, investment, and private banking needs of its clients in the life sciences sector, helping them to innovate and grow in a rapidly evolving field.  

​DLA Piper

​From the lab to the marketplace, life sciences has a challenging legal landscape. DLA Piper understands today’s complex business and regulatory environments around the world. Our Life Sciences team is one of the largest and most active of any law firm. Our award-winning lawyers can help with all your legal needs, including litigation, regulation, compliance and investigations, IP strategy and enforcement, data privacy, finance, M&A, and licensing and distribution.  See our DLA Piper Life Sciences capabilities page for additional information.